Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1991-11-12 (34 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: LE LAMENTIN (97232), Martinique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
BIOLOGIE REACTIF ET LABORATOIRE : revenue, balance sheet and financial ratios
BIOLOGIE REACTIF ET LABORATOIRE is a French company
founded 34 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in LE LAMENTIN (97232),
this company of category PME
shows in 2024 a net income positive of 45 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - BIOLOGIE REACTIF ET LABORATOIRE (SIREN 383679156)
Indicator
2024
2023
2020
2019
Revenue
N/C
N/C
N/C
N/C
Net income
45 389 €
25 283 €
88 082 €
59 804 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, BIOLOGIE REACTIF ET LABORATOIRE generates positive net income of 45 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 60 k€ -> 45 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
45 389 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8.558%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.868%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution BIOLOGIE REACTIF ET LABORATOIRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2023
2024
Debt ratio
0.071
25.482
14.715
8.558
Financial autonomy
54.627
45.773
50.972
49.868
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
8.562024
2020
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average
In 2024, the debt ratio of BIOLOGIE REACTIF ET LABOR... (8.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.87%2024
2020
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Good
In 2024, the financial autonomy of BIOLOGIE REACTIF ET LABOR... (49.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 206.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
206.977
Liquidity indicators evolution BIOLOGIE REACTIF ET LABORATOIRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2023
2024
Liquidity ratio
216.741
229.591
224.658
206.977
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
206.982024
2020
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Good
In 2024, the liquidity ratio of BIOLOGIE REACTIF ET LABOR... (206.98) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of BIOLOGIE REACTIF ET LABORATOIRE in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of BIOLOGIE REACTIF ET LABORATOIRE is estimated at
37 287 €
(range 14 191€ - 136 170€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
14k€37k€136k€
37 287 €Range: 14 191€ - 136 170€
NAF 5 all-time
Valuation method used
Net Income Multiple
45 389 €
×
0.8x
=37 288 €
Range: 14 192€ - 136 170€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare BIOLOGIE REACTIF ET LABORATOIRE with other companies in the same sector:
Frequently asked questions about BIOLOGIE REACTIF ET LABORATOIRE
What is the revenue of BIOLOGIE REACTIF ET LABORATOIRE ?
The revenue of BIOLOGIE REACTIF ET LABORATOIRE is not publicly disclosed (confidential accounts filed with INPI).
Is BIOLOGIE REACTIF ET LABORATOIRE profitable?
Yes, BIOLOGIE REACTIF ET LABORATOIRE generated a net profit of 45 k€ in 2024.
Where is the headquarters of BIOLOGIE REACTIF ET LABORATOIRE ?
The headquarters of BIOLOGIE REACTIF ET LABORATOIRE is located in LE LAMENTIN (97232), in the department Martinique.
Where to find the tax return of BIOLOGIE REACTIF ET LABORATOIRE ?
The tax return of BIOLOGIE REACTIF ET LABORATOIRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does BIOLOGIE REACTIF ET LABORATOIRE operate?
BIOLOGIE REACTIF ET LABORATOIRE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart